[Usefulness of human atrial natriuretic peptide in neurosurgical perioperative management].

No Shinkei Geka

Department of Neuroanesthesia, Kohnan Hospital, Taihaku-ku, Sendai-shi, Miyagi, Japan.

Published: August 2008

Purpose: Intensive hypotension is an important technique in neurosurgical perioperative management. However, it could decrease urine volume, and induce fluid retention resulting in cardiac failure. We evaluated the efficacy of human atrial natriuretic peptide (hANP) on diuresis in a hypotensive condition.

Methods: In 245 patients undergoing neurosurgical operations under general anesthesia in our hospital, 26 patients demonstrated a urine volume less than 50 ml/h at 1 hour after the skin incision, despite receiving a large volume of intravenous fluid. In these 26 patients, we administered hANP (0.05 microg/kg/min) continuously, and evaluated the effect of hANP on diuresis in a hypotensive condition.

Results: After the administration of hANP, the urine volume increased significantly (p<0.01) from 28.7 to 229.4 (ml/h, mean). The heart rate increased from 66.6 to 71.7 (bpm, mean), whereas the systolic blood pressure decreased from 110.3 to 102.2 (mmHg, mean). The electrocardiogram did not change during the administration of hANP.

Conclusions: Despite the hypotensive condition, hANP showed a strong diuretic effect in our study. In neurosurgical perioperative management, administration of hANP can be a useful tool for a fluid balance in the patient.

Download full-text PDF

Source

Publication Analysis

Top Keywords

urine volume
12
human atrial
8
atrial natriuretic
8
natriuretic peptide
8
neurosurgical perioperative
8
hanp diuresis
8
diuresis hypotensive
8
[usefulness human
4
peptide neurosurgical
4
perioperative management]
4

Similar Publications

This was an original article, and the objective of this study was to investigate the effects of bipolar transurethral plasma kinetic prostatectomy (TUPKP) on urodynamics and sexual function in benign prostatic hyperplasia (BPH) patients. One hundred and four BPH patients were divided into a control group and an intervention group. The control group received transurethral resection of prostate, while the intervention group received TUKEP.

View Article and Find Full Text PDF

Even in current guideline-directed medical therapy, including recently introduced vasopressin type 2 receptor antagonist tolvaptan, congestion has not been resolved in patients with heart failure. Kampo medicine goreisan has been receiving considerable attention as an additional therapy for patients who are refractory to conventional diuretics therapy, including tolvaptan. However, the impact of goreisan on urine electrolytes remains uncertain.

View Article and Find Full Text PDF

: The aim of the study was to assess the effect of high-intensity focused electromagnetic (HIFEM) technology in the treatment of female stress urinary incontinence (SUI). : 20 women with SUI were delivered a treatment course with HIFEM technology. Patients attended 6 therapies scheduled twice a week.

View Article and Find Full Text PDF

Purpose: We aimed to assess the clinical efficacy and safety of combining silodosin and solifenacin for overactive bladder (OAB) in females.

Methods: A retrospective analysis of 586 females with OAB was conducted. Patients received either combination therapy (silodosin 8 mg + solifenacin 5 mg) or monotherapy (solifenacin 5 mg) for 12 weeks.

View Article and Find Full Text PDF

Objectives: This study aimed to evaluate the clinical efficacy and safety of silodosin in female patients with lower urinary tract symptoms (LUTSs), addressing the limited evidence supporting alpha-blocker use in this population.

Methods: A 12-week, single-arm, prospective, open-label study was conducted from May 2021 to January 2023. Female patients aged over 18 with an International Prostate Symptom Score (IPSS) ≥ 8 were enrolled and treated with silodosin (8 mg once daily).

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!